HOME
ABOUT IAC
CONTACT
A-Z INDEX
DONATE
SHOP
SUBSCRIBE
Immunize.org logo formerly Immunization Action Coalition (IAC)
IAC Home
|
Technically Speaking
|
September 2016
Technically Speaking
Monthly Column by Deborah Wexler, MD
Deborah Wexler MD
Technically Speaking is a monthly column written by IAC’s Executive Director Deborah Wexler, MD. The column is featured in The Children's Hospital of Philadelphia Vaccine Education Center’s (VEC's) monthly e-newsletter for healthcare professionals. Technically Speaking columns cover practical topics in immunization delivery such as needle length, vaccine administration, cold chain, and immunization schedules.
Check out a recent issue of Vaccine Update for Healthcare Providers. The VEC e-newsletter keeps providers up to date on vaccine-related issues and includes reviews of recently published journal articles, media recaps, announcements about new resources, and a regularly updated calendar of events.
TECHNICALLY SPEAKING
What’s New in the Influenza Vaccination Recommendations for the 2016-17 Season?
Published September 2016
Information presented in this article may have changed since the original publication date. For the most current immunization recommendations from the Advisory Committee on Immunization Practices, visit www.immunize.org/acip/acip_vax.asp.
On Aug. 26, CDC’s Advisory Committee on Immunization Practices (ACIP) recommendations for influenza vaccination for the 2016-17 season were published in Morbidity and Mortality Weekly Report, Recommendations and Reports, Vol 65, No.5.

ACIP continues to recommend routine annual influenza vaccination for all persons 6 months of age and older who do not have a contraindication for vaccination.

Two important new recommendations were made for the 2016-17 season.

  • Live attenuated influenza vaccine (LAIV, FluMist®, AstraZeneca) is not recommended to be used in any setting during the 2016-17 influenza season. This recommendation was made because of evidence of low vaccine effectiveness among children 2 through 17 years of age against the H1N1 strain of influenza virus during the 2013–14 and 2015–16 seasons. Only inactivated or recombinant influenza vaccines should be used during the upcoming influenza season.
  • A history of egg allergy is no longer considered to be a contraindication or precaution to influenza vaccination. Multiple studies have found that severe allergic reactions to egg-based influenza vaccines in persons with egg allergy are unlikely. For the 2016–17 influenza season, ACIP recommends that people with a history of egg allergy who have experienced only hives after exposure to egg should receive any inactivated influenza vaccine without specific precautions (except for the recommended 15-minute observation period for syncope for any vaccine). People who report having had an anaphylactic reaction to egg may also receive any age-appropriate influenza vaccine. The vaccine should be administered in a medical setting such as a hospital, clinic, health department, or physician office. Vaccine administration should be supervised by a healthcare provider who is able to recognize and manage severe allergic conditions. Although not specifically recommended by ACIP, providers may prefer an egg-free recombinant vaccine (FluBlok®, Protein Sciences) for people age 18 years and older with severe egg allergy. More information on influenza vaccination and egg allergy is available on IAC’s website.

A new influenza vaccine is available for the 2016-17 season. Fluad™ (Seqirus) is a trivalent inactivated vaccine approved by the Food and Drug Administration for persons 65 years of age and older. It is the first influenza vaccine licensed in the United States that contains an adjuvant (a substance added to a vaccine to improve its immunogenicity). Several other vaccines have new quadrivalent formulations or age indications. This information is summarized in a handy IAC document titled Influenza Vaccine Products for the 2016-17 Influenza Season. It also includes helpful billing code information.

ACIP continues to state no preference for any brand or formulation of influenza vaccine over another where more than one type of vaccine is appropriate and available.

Vaccination is especially important for people who are at increased risk for severe complications from influenza, or at higher risk for influenza-related outpatient, emergency department, or hospital visits. If the vaccine supply were limited, vaccination efforts should focus on delivering vaccination to the following people:

  • All children 6 through 59 months of age
  • All people 50 years of age and older
  • Adults and children who have chronic pulmonary (including asthma), cardiovascular (excluding isolated hypertension), renal, hepatic, neurologic, hematologic or metabolic disorders
  • People with immunosuppression
  • Women who are or will be pregnant during influenza season
  • Children and teens 6 months through 18 years of age who receive chronic aspirin therapy (because of the risk for Reye syndrome after influenza virus infection)
  • American Indians/Alaska Natives
  • People who are extremely obese (body mass index of 40 or higher)

Resources

2016 ISSUES >> view all
NOVEMBER 2016
Who Needs Hepatitis B Serologic Testing before or after Vaccination?
OCTOBER 2016
Hepatitis B Vaccination for Adults — Who Needs It and When?
SEPTEMBER 2016
What’s New in the Influenza Vaccination Recommendations for the 2016-17 Season?
AUGUST 2016
Let's Review — Routine Hepatitis B Vaccination Schedules For Infants, Children and Teens
JULY 2016
How You Can Help Overcome Low Vaccination Rates among Adults
JUNE 2016
Give a Strong Recommendation for HPV Vaccine for All Preteens and Young Adults
MAY 2016
Just Released! IAC's May Edition of Needle Tips
APRIL 2016
CDC Experts Answer 1,000+ Vaccine-related Questions at Immunize.org
MARCH 2016
Using Standing Orders to Vaccinate Increases Coverage Rates and Protects Patients
FEBRUARY 2016
Just Released! CDC's Official Immunization Schedules for 0- to 18-year-olds and for Adults
JANUARY 2016
Remember to Routinely Administer TWO Pneumococcal Vaccines One Year Apart to Healthy Adults Age 65 and Older
 
This page was updated on October 17, 2016
This page was reviewed on October 17, 2016
 
- Guide to immunize.org -
A-Z INDEX
ABOUT IAC
IAC in the News
Staff
IAC History through Film
ACIP
RECOMMENDATIONS
ADOLESCENT VACCINATION
ADULT VACCINATION
ADULT VACCINATION GUIDE
ASK THE EXPERTS
Administering Vaccines
COVID-19
COVID-19 & Routine Vac
Hepatitis B
MMR
Storage and Handling
>> view all
BECKY PAYNE AWARD
BILLING & CODING
BIRTH DOSE GUIDEBOOK
CALENDAR OF EVENTS
CDC INFORMATION
CDC SCHEDULES
CLINIC TOOLS
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Screening for Contraindications
Storage & Handling
Vaccination and COVID-19
Vaccine Recommendations
>> view all
COALITIONS FOR
IMMUNIZATION
CONTRIBUTE TO IAC
COVID-19 RELATED
Ask the Experts: COVID-19
Ask the Experts: COVID-19
   & Routine Vac
Clinic Tools: Vaccination and
   COVID-19
Repository of Resources
Vaccines: COVID-19
DEAR COLLEAGUE LETTERS
16-year-old Visit
HPV
MenACWY Dose #2
DONATE TO IAC
EDUCATIONAL MATERIALS
EMAIL NEWS SERVICES
E-NEWSLETTER: IZ EXPRESS
EXEMPTIONS
FAQs
FAVORITES
FDA PACKAGE INSERTS
FILMS ABOUT IAC
GIVE BIRTH TO THE
END OF HEP B
HANDOUTS FOR
PATIENTS & STAFF
View All Materials
Administering Vaccines
Adolescent Vaccination
Adult Vaccination
Contraindications / Precautions
Documenting Vaccination
Healthcare Personnel
Managing Vaccine Reactions
Parent Handouts
Pregnancy and Vaccines
Q&As: Diseases and Vaccines
Schedules for Patients
Screening Checklists
Standing Orders Templates
Storage & Handling
Strategies & Policies
Temperature Logs
Top Handouts
Vaccine Confidence
Vaccine Recommendations
>> view all
HEP B BIRTH DOSE
HONOR ROLLS
Hep B Birth Dose
Mandatory Flu Vaccination for HCP
MenB Vaccination for Colleges
IZ EXPRESS
Subscribe to IZ Express
IMAGE LIBRARY
LAWS AND MANDATES
MANUFACTURERS
MASS VACCINATION
RESOURCES
NATIONAL ADULT &
INFLUENZA
IMMUNIZATION SUMMIT
NEWS & INFORMATION
NEWSLETTER SIGN UP
OFFICIAL RELEASES
ACIP
CDC
FDA
PACKAGE INSERTS
PARTNERS
PHARMACISTS
PHOTOS
PREGNANCY AND
VACCINES
PRESS ROOM
PROTECT NEWBORNS
FROM HEP B
PUBLICATIONS
IZ Express
Vaccinating Adults:
   A Step-by-Step Guide
Hepatitis B What Hospitals
   Need to Do to
   Protect Newborns
Needle Tips Archive
Vaccinate Adults Archive
Vaccinate Women Archive
REGISTRIES
SCHOOL VACCINATION REQUIREMENTS
SHOP IAC
DVD Immunization Techniques
Laminated Schedules
Patient Record Cards
Flu Vaccine Buttons and Stickers
"Vaccines Save Lives" Pins
SITE MAP
STANDING ORDERS
STATE INFORMATION
Immunization Websites
Laws and Mandates for School Entry
Immunization Program Managers
SUBSCRIBE TO IZ EXPRESS
SUPPORT IAC
TALKING ABOUT VACCINES
Adjuvants & Ingredients
Autism
Importance of Vaccination
MMR Vaccine
Religious Concerns
Vaccine Safety
>> view all
TECHNICALLY SPEAKING
(ARCHIVE)
TRANSLATIONS
IAC Handouts
VISs
TRAVEL (INTERNATIONAL)
UNPROTECTED PEOPLE
STORIES
Chickenpox
Hepatitis B
Measles
Whooping Cough
>> view all
VACCINATING ADULTS:
A STEP-BY-STEP GUIDE
VACCINE INFORMATION
STATEMENTS
Translations
VACCINE
MANUFACTURERS
VACCINE POLICY &
LICENSURE
ACIP
FDA
WHO
VACCINE SAFETY
VACCINE TIMELINE
VACCINES
COVID-19
Hepatitis B
HPV (Human papillomavirus)
Influenza
Monkeypox
Pertussis
Varicella
>> view all
VIDEO OF THE WEEK
VIDEO LIBRARY
VISs
Translations
WHAT'S NEW OR UPDATED AT IAC
Handouts
VISs and Translations
Web Pages
 
Immunize.org  •  2136 Ford Parkway  •  Suite 5011  •  Saint Paul, Minnesota  •  55116
tel 651-647-9009  •  fax 651-647-9131
 
 
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 1NH23IP922654) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.